Are we over-diagnosing Bipolar Disoder? The utility of the MDQ in a rural clinic by the US-Mexico 
Border. 
Jorge Gaspar, MD1; Alvaro Camacho, MD1,2; Bernardo Ng, MD1,2; Alan Simmons, PhD2; 
Ipsit Vahia, MD1,2; Scott C Matthew, MD2; Mark A Frye, MD3. 
1Sun Valley Behavioral and Research Center. Imperial, CA. 
2Department of Psychiatry. University of California, San Diego 
3Department of Psychiatry. Mayo Clinic. Rochester, MN. 
Background: The Mood Disorder Questionnaire (MDQ) is a useful screening instrument for bipolar 
spectrum disorders in the psychiatric outpatient population; a score of 7 or more items yields good 
sensitivity (0.73) and very good specificity (0.9) (1). Recently the literature has raised concerns about 
not only the under diagnosis but also the over diagnosis of Bipolar Disorder (2). 
Objective: To demonstrate the usefulness of the MDQ as practical screening tool to prevent the over and 
under diagnosis of Bipolar disorder a in a rural clinic in southern California. 
Methods: A cross-sectional chart reviewed from January until December of 2009 done by an 
independent researcher (JG), not involved in the treatment of patients. Basic demographics, initial 
diagnosis and MDQ outcomes were extracted from patients’ charts. 
Results: A total of 147 medical records were reviewed. The mean age was 38.1 (sd 1.1); 93 (45%) male 
and 54 (26%) female. Seventy eight (37%) were Hispanic, 66 (32%) Caucasians, two African-American 
and one Native-American. Of the 147 reviewed, 54 patients (26%) were diagnosed with a Bipolar 
disorder (26%) , 51 (24%) with depression, and 24 (12%) with an anxiety disorder. Interestingly, the 
MDQ was negative in 62% (34/55) of patients initially diagnosed with Bipolar Disorder. Conversely, 
29% (7/24) of patient with an initial diagnosis of anxiety and 28.8% (15/52) with an initial diagnosis of 
depression had a positive MDQ. 
Discussion: Even though our findings showed only statistical trends, they are of clinical usefulness 
because: a) In our sample, approximately 30% of patients continue to present with depression as the 
initial manifestation of an underlying Bipolar disorder; b) Close to 1/3 of our sample presented with an 
anxious diathesis that belonged to the Bipolar spectrum, which seems to be quite common in our 
Hispanic sample; c) Near two thirds of patients who reported symptoms consistent with a Bipolar 
disorder, were actually MDQ negative. 
Conclusion This pilot data shows that the MDQ is useful not only for screening patients with 
unsuspected bipolar disorder but also to corroborate possible over diagnosis of this condition. These 
clinical observations from a busy rural clinic underscore the importance of implementing standardized 
rating scales to operationalize different psychiatric symptoms. 
Even thought this is a small sample, future studies might look at the association of the anxiety-bipolar 
spectrum with standardized diagnostic tools, especially in rural community clinics with 
predominantly Hispanic patients where these diagnoses tend to overlap.
References 
1. Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE Jr, Lewis L, McElroy 
SL, Post RM, Rapport DJ, Russell JM, Sachs GS, Zajecka J. Development and validation of a 
screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire Am J 
Psychiatry. 2000;157(11):1873-5. 
2. Zimmerman M, Ruggero CJ, Chelminski I, Young D. Is bipolar disorder overdiagnosed? 
J Clin Psychiatry. 2008;69(6):935-40.

Abstract IPS Boston

  • 1.
    Are we over-diagnosingBipolar Disoder? The utility of the MDQ in a rural clinic by the US-Mexico Border. Jorge Gaspar, MD1; Alvaro Camacho, MD1,2; Bernardo Ng, MD1,2; Alan Simmons, PhD2; Ipsit Vahia, MD1,2; Scott C Matthew, MD2; Mark A Frye, MD3. 1Sun Valley Behavioral and Research Center. Imperial, CA. 2Department of Psychiatry. University of California, San Diego 3Department of Psychiatry. Mayo Clinic. Rochester, MN. Background: The Mood Disorder Questionnaire (MDQ) is a useful screening instrument for bipolar spectrum disorders in the psychiatric outpatient population; a score of 7 or more items yields good sensitivity (0.73) and very good specificity (0.9) (1). Recently the literature has raised concerns about not only the under diagnosis but also the over diagnosis of Bipolar Disorder (2). Objective: To demonstrate the usefulness of the MDQ as practical screening tool to prevent the over and under diagnosis of Bipolar disorder a in a rural clinic in southern California. Methods: A cross-sectional chart reviewed from January until December of 2009 done by an independent researcher (JG), not involved in the treatment of patients. Basic demographics, initial diagnosis and MDQ outcomes were extracted from patients’ charts. Results: A total of 147 medical records were reviewed. The mean age was 38.1 (sd 1.1); 93 (45%) male and 54 (26%) female. Seventy eight (37%) were Hispanic, 66 (32%) Caucasians, two African-American and one Native-American. Of the 147 reviewed, 54 patients (26%) were diagnosed with a Bipolar disorder (26%) , 51 (24%) with depression, and 24 (12%) with an anxiety disorder. Interestingly, the MDQ was negative in 62% (34/55) of patients initially diagnosed with Bipolar Disorder. Conversely, 29% (7/24) of patient with an initial diagnosis of anxiety and 28.8% (15/52) with an initial diagnosis of depression had a positive MDQ. Discussion: Even though our findings showed only statistical trends, they are of clinical usefulness because: a) In our sample, approximately 30% of patients continue to present with depression as the initial manifestation of an underlying Bipolar disorder; b) Close to 1/3 of our sample presented with an anxious diathesis that belonged to the Bipolar spectrum, which seems to be quite common in our Hispanic sample; c) Near two thirds of patients who reported symptoms consistent with a Bipolar disorder, were actually MDQ negative. Conclusion This pilot data shows that the MDQ is useful not only for screening patients with unsuspected bipolar disorder but also to corroborate possible over diagnosis of this condition. These clinical observations from a busy rural clinic underscore the importance of implementing standardized rating scales to operationalize different psychiatric symptoms. Even thought this is a small sample, future studies might look at the association of the anxiety-bipolar spectrum with standardized diagnostic tools, especially in rural community clinics with predominantly Hispanic patients where these diagnoses tend to overlap.
  • 2.
    References 1. HirschfeldRM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE Jr, Lewis L, McElroy SL, Post RM, Rapport DJ, Russell JM, Sachs GS, Zajecka J. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire Am J Psychiatry. 2000;157(11):1873-5. 2. Zimmerman M, Ruggero CJ, Chelminski I, Young D. Is bipolar disorder overdiagnosed? J Clin Psychiatry. 2008;69(6):935-40.